Diagnostic Performance of PET and Perfusion-Weighted Imaging in Differentiating Tumor Recurrence or Progression from Radiation Necrosis in Posttreatment Gliomas: A Review of Literature-Reference-Cited by-同舟云学术

Diagnostic Performance of PET and Perfusion-Weighted Imaging in Differentiating Tumor Recurrence or Progression from Radiation Necrosis in Posttreatment Gliomas: A Review of Literature

Published:2020-08-27 Issue: Volume: Page:
ISSN:0195-6108
Container-title:American Journal of Neuroradiology
language:en
Short-container-title:AJNR Am J Neuroradiol

Author:

Soni N.^ORCID,Ora M.^ORCID,Mohindra N.^ORCID,Menda Y.^ORCID,Bathla G.^ORCID

Publisher

American Society of Neuroradiology (ASNR)

Subject

Neurology (clinical),Radiology, Nuclear Medicine and imaging

Reference81 articles.

1. New therapeutic approaches for malignant glioma: in search of the Rosetta stone

2. Recurrent Glioblastoma: Where we stand

3. Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies

4. Perfusion MRI in treatment evaluation of glioblastomas: Clinical relevance of current and future techniques

5. Radiation Necrosis, Pseudoprogression, Pseudoresponse, and Tumor Recurrence: Imaging Challenges for the Evaluation of Treated Gliomas

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ASL, DSC, DCE perfusion MRI and 18F-DOPA PET/CT in differentiating glioma recurrence from post-treatment changes;La radiologia medica;2024-08-08

2. Brain and Brain Stem Necrosis After Reirradiation for Recurrent Childhood Primary Central Nervous System Tumors: A PENTEC Comprehensive Review;International Journal of Radiation Oncology*Biology*Physics;2024-06

3. Surgical treatment of small recurrent gliomas based on MR imaging examination;Medical Engineering & Physics;2024-04

4. MRI Treatment Response Assessment Maps (TRAMs) for differentiating recurrent glioblastoma from radiation necrosis;Journal of Neuro-Oncology;2024-01-23

5. Low rCBV values in glioblastoma tumor progression under chemoradiotherapy;Neuroradiology;2024-01-06